NASDAQ : PETS

PetMed Express, Inc. — Financial statements

Healthcare · Pharmaceutical Retailers · United States

Last price 1.18 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 24.84M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

PetMed Express, Inc. (PETS) reported revenue of 168.86M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year April - March; amounts in USD.

TTMFY2026FY2025FY2024FY2023FY2022
Revenue168.86M179.02M226.97M274.10M247.57M272.28M
Cost of Revenue121.71M128.81M157.84M189.33M171.07M195.34M
Gross Profit47.15M50.22M69.14M84.77M76.50M76.94M
Selling, General & Admin65.73M69.22M71.57M85.25M65.70M49.91M
Other Operating Expenses-1.18M-1.09M344.00K
Operating Expenses74.99M78.60M77.43M91.22M69.59M52.65M
Operating Income-27.84M-28.39M-8.29M-6.45M6.92M24.29M
Interest Expense-140.00K-1.13M
Interest & Investment Income511.00K511.00K185.00K511.00K450.00K
Other Non Operating Income (Expenses)1.05M803.00K758.00K1.38M944.00K1.03M
EBT Excluding Unusual Items-26.41M-27.07M-7.35M-4.56M8.31M24.18M
Merger & Restructuring Charges-1.70M-1.70M-1.20M-500.00K
Impairment of Goodwill-27.26M-1.20M
Other Unusual Items-1.23M-1.33M7.96M-512.00K-364.00K
Pretax Income-29.35M-57.36M-587.00K-6.27M7.45M24.18M
Income Tax Expense-69.00K-73.00K5.68M1.19M2.31M5.47M
Net Income-29.28M-57.29M-6.27M-7.46M5.14M18.72M
Net Income to Common-29.28M-57.29M-6.27M-7.46M5.14M18.72M
Shares Outstanding (Basic)21.15M20.92M20.60M20.40M20.27M20.18M
Shares Outstanding (Diluted)21.15M20.92M20.60M20.40M20.34M20.36M
EPS (Basic)-1.38-2.74-0.30-0.370.250.93
EPS (Diluted)-1.38-2.74-0.30-0.370.250.92
Free Cash Flow-27.77M-33.01M-395.00K-194.00K22.54M16.75M
Free Cash Flow Per Share-1.31-1.58-0.02-0.011.110.82
Dividend Per Share0.601.201.20
Gross Margin27.92%28.05%30.46%30.93%30.90%28.26%
Operating Margin-16.49%-15.86%-3.65%-2.35%2.79%8.92%
Profit Margin-17.34%-32.00%-2.76%-2.72%2.08%6.87%
Free Cash Flow Margin-16.45%-18.44%-0.17%-0.07%9.11%6.15%
EBITDA-18.59M-19.00M-1.25M606.00K10.46M27.03M
EBITDA Margin-11.01%-10.61%-0.55%0.22%4.23%9.93%
D&A For EBITDA9.25M9.39M7.04M7.06M3.55M2.74M
EBIT-27.84M-28.39M-8.29M-6.45M6.92M24.29M
EBIT Margin-16.49%-15.86%-3.65%-2.35%2.79%8.92%
Effective Tax Rate30.96%22.61%
Advertising Expenses21.51M23.78M30.63M25.19M18.80M

Balance sheet

Fiscal year April - March; amounts in USD.

TTMFY2026FY2025FY2024FY2023FY2022
Cash & Equivalents13.08M21.41M54.72M55.30M104.09M111.08M
Cash & Short-Term Investments13.08M21.41M54.72M55.30M104.09M111.08M
Receivables1.71M1.91M2.32M3.28M1.74M1.91M
Inventory8.47M13.61M16.20M28.56M19.02M32.45M
Prepaid Expenses4.26M6.38M5.33M6.33M4.72M4.87M
Other Current Assets96.00K258.00K299.00K188.00K863.00K681.00K
Total Current Assets27.61M43.56M78.87M93.65M130.43M151.00M
Property, Plant & Equipment25.61M26.84M29.82M28.09M26.18M24.46M
Long-Term Investments5.30M5.30M5.30M5.00M
Goodwill26.66M26.66M
Other Intangible Assets5.25M5.49M8.05M11.20M860.00K860.00K
Long-Term Deferred Tax Assets4.99M5.01M3.38M
Total Assets63.76M81.19M148.70M169.88M167.48M179.70M
Accounts Payable12.30M20.91M23.56M37.02M25.21M27.50M
Accrued Expenses27.26M27.76M34.64M28.44M29.16M26.38M
Current Portion of Leases414.00K493.00K461.00K459.00K
Current Income Taxes Payable20.00K80.00K
Current Unearned Revenue629.00K2.63M3.77M4.45M1.66M1.62M
Other Current Liabilities229.00K251.00K1.78M1.48M748.00K
Total Current Liabilities40.60M52.03M62.77M72.16M57.51M56.25M
Long-Term Leases42.00K535.00K995.00K
Long-Term Deferred Tax Liabilities175.00K175.00K263.00K
Total Liabilities40.77M52.25M63.57M73.15M57.51M56.25M
Common Stock22.00K21.00K21.00K21.00K21.00K21.00K
Additional Paid-In Capital19.84M19.65M18.56M25.15M18.28M11.66M
Retained Earnings3.12M9.26M66.54M71.56M91.66M111.76M
Total Common Equity22.98M28.93M85.12M96.72M109.96M123.44M
Shareholders' Equity22.99M28.94M85.13M96.73M109.97M123.45M
Total Liabilities & Equity63.76M81.19M148.70M169.88M167.48M179.70M
Total Debt414.00K535.00K996.00K1.45M
Net Cash (Debt)12.66M20.88M53.72M53.84M104.09M111.08M
Net Cash Per Share0.601.002.612.645.125.46
Filing Date Shares Outstanding21.05M21.03M20.99M19.87M20.45M20.22M
Total Common Shares Outstanding21.06M21.05M20.64M20.45M20.33M20.21M
Working Capital-12.99M-8.47M16.10M21.49M72.92M94.75M
Book Value Per Share1.091.374.124.735.416.11
Tangible Book Value17.73M23.44M50.42M58.86M109.10M122.58M
Tangible Book Value Per Share0.841.112.442.885.376.07
Land3.70M3.70M3.70M3.70M3.70M
Buildings19.51M19.63M19.51M18.91M17.83M
Machinery9.08M9.43M9.33M9.40M9.11M

Cash flow statement

Fiscal year April - March; amounts in USD.

TTMFY2026FY2025FY2024FY2023FY2022
Net Income-29.28M-57.29M-6.27M-7.46M5.14M18.72M
Depreciation & Amortization9.25M9.39M7.04M7.06M3.55M2.74M
Asset Writedown & Restructuring Costs27.26M1.20M
Stock-Based Compensation972.00K1.36M-6.59M6.87M6.62M4.55M
Provision & Write-off of Bad Debts-30.00K-36.00K365.00K324.00K214.00K165.00K
Other Operating Activities-690.00K-690.00K5.25M292.00K-1.63M-846.00K
Change in Accounts Receivable-71.00K445.00K601.00K-1.74M-41.00K509.00K
Change in Inventory7.77M471.00K12.35M-6.42M13.43M1.97M
Change in Accounts Payable-7.74M-2.66M-13.46M6.10M-2.29M-12.05M
Change in Unearned Revenue-479.00K-1.40M-518.00K-390.00K
Change in Income Taxes99.00K-19.00K-31.00K675.00K-182.00K278.00K
Change in Other Net Operating Assets-3.61M-5.24M4.78M-988.00K3.00M2.47M
Operating Cash Flow-23.81M-28.39M4.72M4.32M27.80M18.50M
Capital Expenditures-3.96M-4.62M-5.11M-4.51M-5.26M-1.75M
Cash Acquisitions-35.86M
Investment in Securities-300.00K-5.00M
Investing Cash Flow-3.96M-4.62M-5.11M-40.67M-10.26M-1.75M
Repurchase of Common Stock-254.00K-278.00K
Common Dividends Paid-20.00K-21.00K-181.00K-12.44M-24.54M-24.38M
Financing Cash Flow-274.00K-299.00K-181.00K-12.44M-24.54M-24.38M
Net Cash Flow-28.05M-33.31M-576.00K-48.79M-6.99M-7.64M
Free Cash Flow-27.77M-33.01M-395.00K-194.00K22.54M16.75M
Free Cash Flow Margin-16.45%-18.44%-0.17%-0.07%9.11%6.15%
Free Cash Flow Per Share-1.31-1.58-0.02-0.011.110.82
Levered Free Cash Flow-15.95M-20.37M-7.15M7.56M24.06M33.88M
Unlevered Free Cash Flow-15.86M-20.37M-7.15M7.56M24.06M34.58M
Cash Income Tax Paid52.00K525.00K130.00K4.31M6.08M
Change in Working Capital-4.04M-8.39M3.72M-2.76M13.92M-6.82M

Ratios

Fiscal year April - March; amounts in USD.

TTMFY2026FY2025FY2024FY2023FY2022
Market Capitalization25.05M48.73M86.43M97.82M330.08M521.92M
Enterprise Value12.39M22.48M37.44M46.19M227.66M413.02M
Last Close Price1.192.284.194.7915.5623.30
PE Ratio64.2227.89
Forward PE92.4492.44106.4424.7323.04
PS Ratio0.150.270.380.361.331.92
PB Ratio1.091.681.011.013.004.23
P/TBV Ratio1.412.081.711.663.034.26
P/FCF Ratio14.6431.17
P/OCF Ratio18.3222.6611.8728.21
PEG Ratio4.384.384.381.901.77
EV/Sales Ratio0.070.130.170.170.921.52
EV/EBITDA Ratio76.2321.7615.28
EV/EBIT Ratio32.9217.00
EV/FCF Ratio10.1024.66
Debt / Equity Ratio0.020.020.010.01
Debt / EBITDA Ratio0.95
Net Debt / Equity Ratio-0.55-0.72-0.63-0.56-0.95-0.90
Net Debt / EBITDA Ratio0.681.1042.88-88.85-9.95-4.11
Net Debt / FCF Ratio0.460.63136.01277.54-4.62-6.63
Asset Turnover1.951.561.431.621.431.48
Inventory Turnover9.078.647.057.966.655.84
Quick Ratio0.360.450.910.811.842.01
Current Ratio0.680.841.261.302.272.68
Return on Equity (ROE)-78.56%-100.44%-6.90%-7.22%4.40%14.14%
Return on Assets (ROA)-20.05%-15.43%-3.25%-2.39%2.49%8.27%
Return on Invested Capital (ROIC)-302.82%-143.83%-22.32%-26.45%52.32%107.62%
Return on Capital Employed (ROCE)-120.20%-97.40%-9.60%-6.60%6.30%19.70%
Earnings Yield-116.32%-117.55%-7.26%-7.63%1.56%3.59%
FCF Yield-110.87%-67.74%-0.46%-0.20%6.83%3.21%
Dividend Yield12.54%7.39%4.65%
Payout Ratio477.37%130.28%
Buyback Yield / Dilution-2.40%-1.58%-0.98%-0.28%0.09%-1.19%
Total Shareholder Return-2.40%-1.58%-0.98%12.26%7.48%3.46%